Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (511-520 of 556) with videos related to

Pageof 56
Sort By:
Journal of Gastroenterology|May 11, 2018
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center studyHiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, et al.
Journal of Viral Hepatitis|May 13, 2022
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study GroupToshie Mashiba, Kouji Joko, Masayuki Kurosaki, et al.
Kidney International Reports|May 14, 2023
Corrigendum to "Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease"Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866Eri Okada, Naoya Morisada, Tomoko Horinouchi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2024
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinomaMichihisa Moriguchi, Keiichiro Okuda, Go Horiguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLDYuya Seko, Taeang Arai, Hirokazu Takahashi, et al.
Cancers|March 27, 2020
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter AnalysisAya Takahashi, Michihisa Moriguchi, Yuya Seko, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2025
Waitlist and Post-Transplant Outcomes in Liver Transplantation for Alcohol-Associated Liver Disease: An Individual Patient Data Meta-AnalysisGlenn Jun Kit Ho, Mirudhula Gnanavelou, Ryan Yanzhe Lim, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 16, 2022
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter studyYuya Seko, Hirokazu Takahashi, Hidenori Toyoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 22, 2023
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver diseaseSatoshi Oeda, Yuya Seko, Hideki Hayashi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 26, 2023
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological responseShun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 56

Showing results (511-520 of 556) with videos related to

Sort By:
Pageof 56
Journal of Gastroenterology|May 11, 2018
The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center studyHiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, et al.
Journal of Viral Hepatitis|May 13, 2022
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study GroupToshie Mashiba, Kouji Joko, Masayuki Kurosaki, et al.
Kidney International Reports|May 14, 2023
Corrigendum to "Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease"Kidney International Reports, Volume 7, Issue 4, April 2022, Pages 857-866Eri Okada, Naoya Morisada, Tomoko Horinouchi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2024
Safety/efficacy of atezolizumab + bevacizumab during anti-platelet/anticoagulation therapy in unresectable hepatocellular carcinomaMichihisa Moriguchi, Keiichiro Okuda, Go Horiguchi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 12, 2026
Optimizing VCTE and ELF Thresholds for Treatment-Eligible F2-F3 Fibrosis in Japanese Patients With MASLDYuya Seko, Taeang Arai, Hirokazu Takahashi, et al.
Cancers|March 27, 2020
Early Tumor Shrinkage as a Predictive Factor for Outcomes in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter AnalysisAya Takahashi, Michihisa Moriguchi, Yuya Seko, et al.
Alimentary Pharmacology & Therapeutics|November 1, 2025
Waitlist and Post-Transplant Outcomes in Liver Transplantation for Alcohol-Associated Liver Disease: An Individual Patient Data Meta-AnalysisGlenn Jun Kit Ho, Mirudhula Gnanavelou, Ryan Yanzhe Lim, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|December 16, 2022
Diagnostic accuracy of enhanced liver fibrosis test for nonalcoholic steatohepatitis-related fibrosis: Multicenter studyYuya Seko, Hirokazu Takahashi, Hidenori Toyoda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 22, 2023
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver diseaseSatoshi Oeda, Yuya Seko, Hideki Hayashi, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|June 26, 2023
Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological responseShun Ishido, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Pageof 56